Clinical Laserthermia Systems AB (CLS-B) Fair Value & Analysis
Healthcare · SE · Market cap 106M SEK
Fair value as of: Jul 12, 2026
From 1 valuation models · updated 9 days ago
Share price −10.8% over the past month.
Price vs Fair Value (12 months)
12‑month range kr 3.15 – kr 11.82 · fair‑value band kr 0.5780 – kr 1.11 · the kr 3.19 price screens above the kr 0.8840 fair value. As of Jul 12, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Clinical Laserthermia Systems AB (CLS-B) currently trades at kr 3.19, while our model-based Fair Value estimate is kr 0.8840, implying the stock looks roughly 72.3% overvalued today. We read business quality at 23/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at 14.3M SEK. Revenue declined 71.6% year over year. It earns a return on equity of -53.2%. The balance sheet holds a net cash position of 21.5M SEK. Fundamentals as of Jul 12, 2026
Our scenario range runs from kr 0.5780 (bear case) to kr 1.11 (bull case); at kr 3.19, the current price sits above that range. The share trades about 76% below its 52-week high and 23% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -22% fair-value upside, at -72%, CLS-B screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 12, 2026. TTM = trailing twelve months.
About the company
Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control treatment. In addition, it offers various gauge laser applicators and introducers, as well as provides temperature and treatment monitoring devices. The company has a strategic partnership with ClearPoint Neuro Inc. for the development of ClearPoint Prism, a Neuro Laser Therapy System. Clinical Laserthermia Systems AB (publ) was incorporated in 2006 and is headquartered in Lund, Sweden.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Clinical Laserthermia Systems AB reported revenue of kr 17.5M in FY2025 versus kr 2.2M in FY2021, a compound +67.1%/yr. Reported net income was −kr 41.6M in FY2025.
Is CLS-B fairly valued? → Check now
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $86.97 | $69.36 | -20% |
| Stryker Corporation SYK | $305.66 | $187.83 | -39% |
| Medtronic plc MDTC34 | R$210.63 | R$24.08 | -89% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EWL | €74.64 | €31.98 | -57% |
| Siemens Healthineers AG SEMHF | $40.29 | $47.96 | +19% |
| DexCom, Inc DXCM | $74.77 | $53.93 | -28% |
| GE HealthCare Technologies Inc GEHC | $61.99 | $48.34 | -22% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥141.85 | ¥147.63 | +4% |
| Koninklijke Philips N.V PHG | $26.98 | $10.24 | -62% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Clinical Laserthermia Systems AB (CLS-B) undervalued?
What is the fair value of CLS-B?
What is the quality score of CLS-B?
What is the revenue of Clinical Laserthermia Systems AB (CLS-B)?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Clinical Laserthermia Systems AB analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.